MGI PHARMA Third Quarter 2007 Financial Results Conference Call to Be Webcast on October 17, 2007
MGI Pharma zu myNews hinzufügen Was ist das?
MGI PHARMA, INC. (Nasdaq:MOGN) will webcast its third quarter
2007 financial results conference call with investors live over the
Internet on Wednesday, October 17, 2007 at 5:00 p.m. Eastern Time.
Lonnie Moulder, President and CEO of MGI PHARMA, and members of the
Company’s executive management team, will
review financial results, answer questions from analysts and investors,
and provide commentary on MGI PHARMA’s
business outlook. A press release announcing the Company’s
financial results for the third quarter 2007 will be issued on
Wednesday, October 17, 2007 after the U.S. financial markets close and
prior to the start of the webcast.
The live webcast and press release may be accessed by logging on to MGI
PHARMA’s corporate website at www.mgipharma.com.
Please connect to the Company’s website at
least 15 minutes prior to the conference call to ensure adequate time
for any software downloads that may be necessary to listen to the
webcast. An archived version of the webcast will be available through
October 24, 2007.
About MGI PHARMA
MGI PHARMA, INC. is a biopharmaceutical company focused in oncology and
acute care that acquires, researches, develops and commercializes
proprietary products that address the unmet needs of patients. MGI
PHARMA has a portfolio of proprietary pharmaceuticals, and intends to
become a leading biopharmaceutical company. MGI PHARMA markets Aloxi®
(palonosetron hydrochloride) Injection, Dacogen®
(decitabine) for Injection and Gliadel® Wafer
(polifeprosan 20 with carmustine implant) in the United States. The
Company directly markets its products in the U.S. and collaborates with
partners to reach international markets.
